Magnesium and Cognition After Stroke

Launched by BDH-KLINIK HESSISCH OLDENDORF · Nov 19, 2021

Keywords

ClinConnect Summary

This clinical trial, titled "Magnesium and Cognition After Stroke," is exploring how magnesium levels in the body might affect thinking and memory in people who have had a stroke. After a stroke, many patients experience difficulties with memory, finding the right words, and understanding their surroundings. Researchers want to find out if low magnesium levels contribute to these cognitive challenges or if they are simply a result of the stroke itself. This study is important because it aims to better understand the relationship between magnesium, how severe the stroke was, and cognitive function in patients during their recovery.

To participate in this trial, individuals aged 65 and older who have experienced either an ischemic (caused by a blocked blood vessel) or hemorrhagic (caused by bleeding in the brain) stroke may be eligible. However, those with pre-existing dementia, certain mental health conditions, or who are currently pregnant or breastfeeding cannot join. Participants will be asked to provide written consent and will be monitored throughout the study to assess their cognitive function and magnesium levels. This research could help improve the care and recovery process for stroke patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ischemic/hemmorhagic stroke
• • written consent form
• Exclusion Criteria:
• • pre-existing dementia or cognitive impairment before stroke onset
• • pre-existing mental disorder (depression) or present/prior long-term treatment (\> 6 months) with psychotropic drugs
• • pre-existing malign tumor disease
• • participation in another clinical trial within the past 30 days
• • pregnancy or breastfeeding